Focus on Alzheimer's Disease Research
Nova Publishers, 2003 - 326 páginas
Dementia is a brain disorder that seriously affects a person's ability to carry out daily activities. The most common form of dementia among older people is Alzheimer's disease (AD), which involves the parts of the brain that control thought, memory, and language. Age is the most important known risk factor for AD. The number of people with the disease doubles every 5 years beyond age 65. AD is a slow disease, starting with mild memory problems and ending with severe brain damage. The course the disease takes and how fast changes occur vary from person to person. On average, AD patients live from 8 to 10 years after they are diagnosed, though the disease can last for as many as 20 years. Current research is aimed at understanding why AD occurs and who is at greatest risk of developing it, improving the accuracy of diagnosis and the ability to identify those at risk, discovering, developing, and testing new treatments, and discovering treatments for behavioural problems in patients with AD. This new book gathers state-of-the-art research from leading scientists throughout the world which offers important information on understanding the underlying causes and discovering the most effective treatments for Alzheimer's Disease.
Comentarios de usuarios - Escribir una reseña
No hemos encontrado ninguna reseña en los sitios habituales.
ABPP allele Alzheimer disease Alzheimer's disease amyloid precursor protein amyloidogenic apolipoprotein apoptosis associated B-amyloid Bahr behavior Bendiske beta beta-amyloid binding blood flow Brain Res C-terminal fragments caregivers carers caspase cathepsin cathepsin D cells cerebral cholesterol cholinergic chromosome circadian cleavage clinical cognitive impairment complex cortex cytochrome cytokines decreased deposition diagnosis disorders dysfunction elderly enzyme estrogen ethical issues evidence expression formation function genetic hippocampal hypometabolism increased induced inflammatory cytokines inhibition inhibitors interaction interleukin-1 intracellular ischemia late-onset levels lipid lysosomal melatonin membrane memory metabolism microtubule molecular mutations Natl Neurobiol neurodegenerative neurofibrillary tangles Neurology neurons Neuropathol Neurosci Neurosci Lett nicastrin onset oxidative stress pathogenesis pathology pathway patients peptide person with dementia phosphorylation phytoestrogens plaques polymorphism presenilin Proc processing protease proteasome proteolytic PS1 and PS2 Psychiatry receptor reduced region reported risk factors role secretase Selkoe sleep studies synaptic Taiwan therapy treatment vascular vascular dementia